CIMT Meetings
CIP co-organizes dedicated immunoguiding sessions at the CIMT Annual Meeting and conferences
CIMT 2018
Day 3 - May 17, 2018 - Plenary session 5: Immunoguiding
Günther J. Hämmerling German Cancer Research Center DKFZ (Heidelberg, Germany)
Reprogramming the tumor microenvironment for efficient cancer immunotherapy
Dimitirios Mastellos National Center for Scientfic Research ‘Demokritos’ (Athens, Greece)
Complement in cancer: untangling an intricate relationship
Nicholas McGranahan, Cancer Research UK Lung Cancer Centre of Excellence (London, United Kingdom)
Lung cancer evolution and immune escape
Day 3 - May 17, Short Talk session V: Immunomonitoring
Rodrigo Nalio Ramos Institute Curie, Paris, France
High dimensional analysis of the myeloid cell landscape in human breast cancer metastatic lymph nodes
Saskia J.A.M. Santegoets Leiden University Medical Center, Leiden, Netherlands
The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival
Tripti Tamhane Technical University of Denmark, Lyngby, Denmark
Empty MHC class I molecules: An alternate, convenient, and improved detection tool for antigen specific T cells
Alexander Ulges Immatics Biotechnologies GmbH, Tübingen, Germany
Immunomonitoring for personalized cancer immunotherapies via ex vivo combinatorial workflow and concurrent high-resolution class I & II ICS
Henning Zelba University Medical Center Tübingen, Tübingen, Germany
Disappearance of NY-ESO-1 and Melan-A-specific T-cells from peripheral blood is associated with clinical response in melanoma patients undergoing anti-PD-1 therapy
For more information, please see the CIMT 2018 meeting program
Immunomonitoring Poster Award
Jonas Bochem, University Medical Center Tübingen
Abstract #034
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, Sept 2017, Mainz
CIP presented a series of posters on all activities of the working group
CIMT 2017 Anniversary Symposium, May 2017
Immunoguiding Seminar Speakers: Javier Romero Ros (Academic Medical Center, Amsterdam), Sven Brandau (University Hospital Essen), Tanja de Gruijl (VU University Medical Center Amsterdam), Angela M. Krackhardt (Technical University Munich)
CIP Meeting events Archive:
CIMT 2016
Day 3 - May 12, 2016 - Plenary session 5: Novel Technologies for Immune Assessment
Timothy Tree King's College (London, United Kingdom)
Measuring regulatory T cell phenotype and function in human health and disease
Sine Reker Hadrup Technical University of Denmark (Copenhagen, Denmark)
Next-generation detection of cancer-responsive T cells
Giuliano Elia, Philochem (Otelfingen, Switzerland)
A phase III trial of the intralesional application of L19IL2/L19TNF in stage IIIB/C melanoma patients
Day 3 - May 12, Short Talk session VI: Immunomonitoring
Amalie Kai Bentzen Technical University of Denmark (Copenhagen, Denmark)
Next-generation detection of cancer-responsive T cells using DNA barcode-labeled
peptide-Major Histocompatibility Complex I multimers
Coco de Koning UMC (Utrecht, The Netherlands)
CD4+ T-cell immunomonitoring after hematopoietic cell transplantation:
identifying patients at risk for virus-predicted adverse outcomes
Gabriele Niedermann University Clinics (Freiburg, Germany)
Noninvasive ImmunoPET imaging of the PD-1/PD-L1 checkpoint in naïve and irradiated tumor-bearing mice
Paulo Rodrigues-Santos Faculdade de Medicina da Universidade de Coimbra (Coimbra, Portugal)
Immune monitoring of natural killer cells in chronic myeloid leukemia:
split anergy status depend on tyrosine kinase inhibitor therapy
Julien Schmidt Ludwig Center (Lausanne, Switzerland)
Isolation and analysis of tumor-specific CD8 and CD4 T cells with high affinity, reversible pMHC multimers
CIMT 2015
Day 1 - May 11, 2015 - Symposium on Computational Tools for Biomarker Discovery
Ryan Brinkman British Columbia Cancer Agency (Vancouver BC, Canada)
Computational tools for flow cytometry and how well they work
Sylvia Janetzki ZellNet Consulting (Fort Lee,USA)
The age of computing: challenges in data analysis for functional immune assays
Tomas Kalina Charles University (Prague, Czech Republic)
How standardization of flow cytometry facilitates computational analyses - EuroFlow experience
Pratip Chattopadhyay National Institutes of Health (Bethesda, USA)
The next dimension in single cell cytometry: integrating computational tools for more powerful experiments
Pia Kvistborg (National Cancer Institute Amsterdam The Netherlands) and Marij Welters (LUMC, Leiden, The Netherlands)
Update on CIP activities and closing words
CIP Committee and Speakers at 2015 CIMT Annual Meeting in Mainz
Day 3 - May 13, 2015 Short talk session VI / Immunomonitoring
Katharina Epp Johannes Gutenberg-Universität (Mainz, Germany)
Functionally impaired GPI-anchor negative regulatory T cells strongly correlate with acute Graft versus Host Disease after Alemtuzumab-based conditioning regimen
Keisuke Fujii University Graduate School of Medicine (Mie, Japan)
Development of a novel rapid and sensitive method for detection of cellular immune responses and selection of immunogenic peptides encoded by mutated genes
Jan Dörrie University Hospital (Erlangen, Germany)
Electroporation of CD8+ effector T cells with antigen is suitable to test their reactivity to tumor antigens
Jithendra Kini Bailur University Hospital (Tübingen, Germany)
Prognostic impact of circulating plasmacytoid dendritic cells and immunosuppressive subsets in breast cancer
Sofie Ramskov Andersen Technical University/National Veterinary Institute (Copenhagen, Denmark)
Identification of novel T cell epitopes in breast cancer
CIMT 2014
Day 1 - May 6, 2014 - CIP Breakout Session
Steffen Walter immatics biotechnologies GmbH (Tübingen, Germany) MDSC Phenotyping Proficiency Panel
Ruth Challis University of Southampton (Southampton, United Kingdom)
Preliminary results from the NK harmonization panel
Henrik Pedersen Immudex (Copenhagen, Denmark)
MHC Multimer Proficiency Panel 2014: The data obtained prove high reproducibility of the MHC Multimer assay
Nicole Bidmon University Medical Center Mainz (Mainz, Germany)
TCR-engineered reference samples (TERS) to control T-cell assay performance –towards an immune-control kit
Saskia Santegoets Leiden University Medical Center (Leiden, The Netherlands)
Results of the CIP workshop on the detection and functional testing of (antigen-specific) regulatory T cells
Pia Kvistborg Netherlands Cancer Institute (Amsterdam, The Netherlands)
Automated analysis of flow cytometry data – bridging two worlds
Cliburn Chan Duke University (Durham, USA)
Managing multi-center flow cytometry data for cancer immune monitoring
Day 2 - May 7, 2014 - Plenary Session 4 / Immunoguiding
Eric Vivier Centre d´Immunologie (Marseille, France)
Natural killer cells and innate lymphoid cells
Pedro Romero Ludwig Institute for Cancer Research (Lausanne, Switzerland)
Monitoring tumor antigen-specific T-cell responses
Day 3 - May 8, 2014 - Short Talk Session V / Immunomonitoring
Petra Baumgärtner Ludwig Institute for Cancer Research (Lausanne, Switzerland)
Survival of melanoma patients correlating with DTH skin reactions and CD8 T cell/ Treg ratios in PBMC after vaccinations with CpG & peptides
Julia Fischer Institute for Virology and Immunobiology (Würzburg, Germany)
Resetting circulating CD8 T-cells to a tissue-like status permits sensitive detection of their responses to virus- and tumor-associated antigens
Michael Hebeisen Lausanne University Hospital (Lausanne, Switzerland)
Reversible NTAmer technology enables rapid and direct detection of monomeric TCRpMHC kinetics at the cell surface and predicts tumor-specific T cell responsiveness
Jithendra Kini Bailur University Hospital (Tübingen, Germany)
Presence of circulating Her-2-reactive CD8 T-cells is associated with lower frequency of MDSCs and better survival in elderly breast cancer patients
Oliver Lantz Institut Curie and INSERM (Paris, France)
High numbers of differentiated effector CD4 T cells are found in cancer patients and correlate with clinical response after neo-adjuvant therapy of breast cancer
